Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

ENDRA Life Sciences Inc. (NDRA)

0.7515   -0.028 (-3.63%) 09-20 19:27
Open: 0.77 Pre. Close: 0.7798
High: 0.79 Low: 0.7463
Volume: 116,206 Market Cap: 16M
ENDRA Life Sciences, Inc. develops medical imaging technology. The company is headquartered in Ann Arbor, Michigan and currently employs 5 full-time employees. The firm's Nexus 128 system combines light-based thermoacoustics and ultrasound, to address the imaging needs of researchers studying disease models in pre-clinical applications. The firm is involved in developing Thermo Acoustic Enhanced Ultrasound (TAEUS) for incorporation into new ultrasound systems. The TAEUS platform has capabilities and potential clinical applications, such as enabling ultrasound to distinguish fat from lean tissue; enabling traditional ultrasound to visualize changes in tissue temperature, in real time; enabling ultrasound to view blood vessels from any angle, using only a saline solution contrasting agent, unlike Doppler ultrasound which requires precise viewing angles, and enabling ultrasound to image blood flow at the capillary level in a region, organ or tissue.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 0.79 - 0.796 0.796 - 0.8
Low: 0.74 - 0.745 0.745 - 0.749
Close: 0.743 - 0.751 0.751 - 0.758

Technical analysis

as of: 2020-09-18 4:33:42 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months:     One year: 1.12
Support: Support1: 0.70    Support2: 0.58
Resistance: Resistance1: 0.86    Resistance2: 0.96
Pivot: 0.79
Moving Average: MA(5): 0.78     MA(20): 0.81
MA(100): 0.88     MA(250): 1.04
MACD: MACD(12,26): -0.04     Signal(9): -0.04
Stochastic oscillator: %K(14,3): 47.05     %D(3): 49.14
RSI: RSI(14): 35.07
52-week: High: 2.25  Low: 0.60  Change(%): -51.1
Average Vol(K): 3-Month: 44454  10-Days: 11870

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
NDRA has closed above bottom band by 13.5%. Bollinger Bands are 49.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to NDRA's normal range. The bands have been in this narrow range for 3 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 15 Sep 2020
ENDRA Life Sciences : to Attend Lake Street's Fourth Annual Best Ideas Growth (BIG4) Conference September 17, 2020 - marketscreener.com

Mon, 14 Sep 2020
ENDRA Life Sciences to Present at the H.C. Wainwright 22nd Annual Global Investment Conference on September 16, 2020 - Yahoo Finance

Tue, 08 Sep 2020
How Should Investors React To ENDRA Life Sciences' (NASDAQ:NDRA) CEO Pay? - Yahoo Finance

Wed, 02 Sep 2020
ENDRA Life Sciences to Present at the LD Micro 500 Virtual Conference - Yahoo Finance

Thu, 27 Aug 2020
ENDRA Life Sciences to showcase TAEUS(R) Technology at EASL International Liver Congress 2020 - BioSpace

Thu, 27 Aug 2020
What’s The Key Support Level On ENDRA Life Sciences Inc. (NDRA)? - Invest Million

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Diagnostics & Research
Shares Out. (M) 21
Shares Float (M) 18
% Held by Insiders 3.45
% Held by Institutions 8.87
Shares Short (K) 596
Shares Short P. Month (K) 567

Stock Financials

EPS -1.745
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 0.060
Profit Margin
Operating Margin
Return on Assets (ttm) -242.9
Return on Equity (ttm) -1030.9
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.557
Qtrly Earnings Growth
Operating Cash Flow (M) -11
Levered Free Cash Flow (M) -6

Stock Valuations

PE Ratio -0.43
PEG Ratio
Price to Book value 12.53
Price to Sales
Price to Cash Flow -1.44

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.